GDEV:NASDAQGDEV Inc. Analysis
Data as of 2026-04-05 - not real-time
$14.90
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
GDEV trades at $14.90, just above the 20‑day SMA of $14.33 but well below the 50‑day ($15.71) and 200‑day ($17.90) averages, reinforcing a bearish price trend. The RSI sits at 51, suggesting neutral momentum, while the MACD histogram is positive (+0.10) indicating a slight short‑term bullish tilt. Current price sits between a solid support level at $11.92 and resistance near $16.08, with volume trending upward and 30‑day volatility soaring above 80%, highlighting a very active but risky trading environment. Valuation metrics are striking: a trailing PE of 3.95 versus an industry average of 17.34, a DCF‑derived fair value of $15.93, and an implied upside of roughly 370%, all pointing to a deeply undervalued stock despite the bearish technical backdrop.
Fundamentally, the company posted a 7.9% revenue decline year‑over‑year but maintains healthy margins (gross 65%, operating 15%, profit 17%) and strong cash ($108 M) with virtually no debt. No dividend is paid, and the book value per share is negative, reflecting accounting nuances. Recent news shows founder‑CEO Andrey Fadeev boosted his ownership to 37%, a confidence signal, while the company released preliminary unaudited Q4 results, underscoring transparency. These factors combine to suggest a value‑oriented opportunity with significant upside potential, tempered by high volatility and a bearish trend.
Fundamentally, the company posted a 7.9% revenue decline year‑over‑year but maintains healthy margins (gross 65%, operating 15%, profit 17%) and strong cash ($108 M) with virtually no debt. No dividend is paid, and the book value per share is negative, reflecting accounting nuances. Recent news shows founder‑CEO Andrey Fadeev boosted his ownership to 37%, a confidence signal, while the company released preliminary unaudited Q4 results, underscoring transparency. These factors combine to suggest a value‑oriented opportunity with significant upside potential, tempered by high volatility and a bearish trend.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Price near strong support with upside to $16.08
- Technical MACD histogram turning positive
- Undervaluation relative to DCF and industry PE
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Valuation cushion remains despite bearish trend
- Robust margins and cash balance
- Revenue contraction and high volatility
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Management confidence evidenced by CEO stake increase
- Potential for new game releases to reverse revenue decline
- Persistent sector and liquidity risks
Key Metrics & Analysis
Financial Health
Revenue Growth-7.90%
Profit Margin17.15%
P/E Ratio4.0
ROA17.60%
P/B Ratio-2.6
Op. Cash Flow$29.4M
Free Cash Flow$13.4M
Industry P/E17.3
Technical Analysis
TrendBearish
RSI51.3
Support$11.92
Resistance$16.08
MA 20$14.33
MA 50$15.71
MA 200$17.90
MACDBullish
VolumeIncreasing
Fear & Greed Index78.8
Valuation
Fair Value$15.93
Target Price$70.00
Upside/Downside369.80%
GradeUndervalued
TypeValue
Risk Assessment
Beta0.66
Volatility81.15%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.